Ondine Biomedical Inc. (AIM:OBI)
London flag London · Delayed Price · Currency is GBP · Price in GBX
13.75
0.00 (0.00%)
Oct 10, 2025, 3:49 PM GMT+1

Ondine Biomedical Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
61362040108-
Upgrade
Market Cap Growth
220.42%79.20%-50.26%-63.06%--
Upgrade
Enterprise Value
58351827127-
Upgrade
Last Close Price
0.140.090.090.200.56-
Upgrade
PS Ratio
51.8131.2627.74101.9672.03-
Upgrade
PB Ratio
157.219.3116.015.596.24-
Upgrade
P/TBV Ratio
157.219.3116.015.596.24-
Upgrade
EV/Sales Ratio
49.5330.8224.9069.7484.97-
Upgrade
Debt / Equity Ratio
0.760.020.260.120.02-1.04
Upgrade
Asset Turnover
0.350.220.110.030.14-
Upgrade
Inventory Turnover
0.580.620.420.301.80-
Upgrade
Quick Ratio
0.761.730.953.417.810.03
Upgrade
Current Ratio
0.972.051.363.878.540.05
Upgrade
Return on Equity (ROE)
-6414.76%-426.20%-209.95%-93.81%--
Upgrade
Return on Assets (ROA)
-235.98%-130.98%-82.98%-46.25%-59.55%-
Upgrade
Return on Capital (ROIC)
-1827.23%-251.32%-118.27%-54.06%-69.33%-
Upgrade
Earnings Yield
-20.94%-29.82%-43.18%-29.78%-27.07%-
Upgrade
FCF Yield
-16.30%-24.20%-41.44%-25.60%-6.82%-
Upgrade
Buyback Yield / Dilution
-68.94%-39.31%-1.30%-144.34%-12.69%-761.95%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.